As our study had led us to a linear mechanism connecting JAM-A, β-catenin, FOXA1 and HER3 (in that order), we analyzed expressional associations between those proteins in the 144-patient breast cancer TMA. This evidence concerns the gene ERBB3 and breast cancer.